Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Atea Pharmaceuticals (AVIR) FCF Margin (2021)

Atea Pharmaceuticals' FCF Margin history spans 1 years, with the latest figure at 39.25% for Q4 2021.

  • Quarterly FCF Margin changed N/A to 39.25% in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 24.76% through Dec 2021, changed N/A year-over-year, with the annual reading at 24.76% for FY2021, 63486.0% down from the prior year.
  • FCF Margin came in at 39.25% for Q4 2021, down from 68.89% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 68.89% in Q3 2021 to a low of 39.25% in Q4 2021.